GLP-1 receptor agonist effects in people with type 2 diabetes using MiniMed™ advanced hybrid closed-loop therapy

被引：0
|
作者：
Shin, J. J. [1 ]
Rhinehart, A. S. [1 ]
Keiter, A. [1 ]
Ma, H. [1 ]
Cordero, T. L. [2 ]
Vigersky, R. A. [2 ]
机构：
[1] Medtron Diabet, Clin Res, Northridge, CA USA
[2] Medtron Diabet, Med Affairs, Northridge, CA USA
来源：
DIABETOLOGIA | 2024年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
775
引用
收藏
页码：S370 / S371
页数：2
相关论文
共 50 条
  • [1] CURRENT ISSUES IN GLP-1 RECEPTOR AGONIST THERAPY FOR TYPE 2 DIABETES
    Bloomgarden, Zachary T.
    Blonde, Lawrence
    Garber, Alan J.
    Wysham, Carol H.
    ENDOCRINE PRACTICE, 2012, 18 : 6 - 26
  • [2] MiniMed™ 780G Advanced Hybrid Closed-Loop System Study in Pregnant Women with Type 1 Diabetes
    Guibert, Clara
    Amoura, Lamia
    Rakotoarisoa, Luc
    Plat, Francoise
    Sonnet, Emmanuel
    Lablanche, Sandrine
    Treglia, Clemence
    Sarde, Elisa
    Leca, Viviane
    Rimareix, Frederique
    Melki, Vincent
    Baucher, Franciane
    Betari, Bouchra
    Meyer, Laurent
    Kessler, Laurence
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 (12) : 893 - 901
  • [3] Exenatide: a GLP-1 receptor agonist as novel therapy for Type 2 diabetes mellitus
    Briones, Mariele
    Bajaj, Mandeep
    EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (08) : 1055 - 1064
  • [4] Effects of the GLP-1 Receptor Agonist on Fatty Liver in Patients With Type 2 Diabetes
    Ogino, Jun
    Yoneda, Chihiro
    Tajima, Kanako
    Ichimura, Yasuhiko
    Fukushima, Sayaka
    Haruki, Takenori
    Sakuma, Yukie
    Iwai, Rie
    Nishino, Takayoshi
    Suzuki, Yoshifumi
    Hashimoto, Naotake
    DIABETES, 2013, 62 : A256 - A257
  • [5] Semaglutide GLP-1 receptor agonist Treatment of type 2 diabetes
    Chudleigh, R.
    Bain, S. C.
    DRUGS OF THE FUTURE, 2017, 42 (08) : 479 - 487
  • [6] Dulaglutide, a GLP-1 receptor agonist, for the treatment of type 2 diabetes
    Clements, Jennifer
    Moore, Katherine
    Shealy, Kayce
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2015, 10 (06) : 581 - 590
  • [7] GLP-1 Receptor Agonist and SGLT2 Inhibitor Prescribing in People With Type 1 Diabetes
    Li, Piaopiao
    Li, Zhiyan
    Staton, Elizabeth
    Umpierrez, Guillermo E.
    Davis, Georgia
    Shao, Hui
    Pasquel, Francisco J.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024,
  • [8] Addition of a GLP-1 Agonist to Insulin Therapy in Type 2 Diabetes
    Gavigan, Colleen
    Donner, Thomas W.
    DIABETES, 2021, 70
  • [9] PREDICTION OF RESPONSE TO GLP-1 RECEPTOR AGONIST THERAPY IN JAPANESE PATIENTS WITH TYPE 2 DIABETES
    Imai, K.
    Tsujimoto, T.
    Goto, A.
    Goto, M.
    Kishimoto, M.
    Yamamoto-Honda, R.
    Noto, H.
    Kajio, H.
    Noda, M.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S258 - S259
  • [10] Prediction of response to GLP-1 receptor agonist therapy in Japanese patients with type 2 diabetes
    Imai, Kenjiro
    Tsujimoto, Tetsuro
    Goto, Atsushi
    Goto, Maki
    Kishimoto, Miyako
    Yamamoto-Honda, Ritsuko
    Noto, Hiroshi
    Kajio, Hiroshi
    Noda, Mitsuhiko
    DIABETOLOGY & METABOLIC SYNDROME, 2014, 6
12345